Is Red Light Therapy Safe? Side Effects, Risks & Myths — The Complete Evidence-Based Guide

Red light therapy side effects are among the most common search queries in this space—and for good reason. Before you invest hundreds of dollars in a panel and spend time in front of bright LEDs, you deserve straightforward, evidence-based answers about whether red light therapy is safe. Not marketing reassurances. Not fear-mongering from competitors. Just what the science actually shows.

The honest answer is that red light therapy has an excellent safety profile compared to most health interventions. Over 4,000 peer-reviewed studies have investigated photobiomodulation, and the consistent finding is that therapeutic red and near-infrared light causes no DNA damage, no carcinogenic effects, and no serious systemic toxicity when used within recommended parameters. The World Association for Laser Therapy (WALT) characterizes it as one of the safest therapeutic modalities available.

That said, "generally safe" does not mean "safe for everyone in every situation." There are real contraindications, genuine medication interactions, and specific populations who should exercise caution or consult a physician before starting. This guide covers all of it—without minimizing actual risks or amplifying theoretical ones. By the end, you'll have a clear, calibrated picture of who can use red light therapy safely, who should proceed with caution, and who should avoid it entirely.

If you're still in the research phase, our complete science guide covers the cellular mechanisms in depth. Once you're confident in safety, our buying guide can help you choose a device, and our protocols guide will help you use it correctly.

The Science of Red Light Safety

To evaluate safety, you need to understand what red light therapy actually is—and more importantly, what it isn't.

Non-Ionizing Radiation: The Critical Distinction

Red light therapy devices emit light in the 630–850nm wavelength range (visible red and near-infrared). This is non-ionizing radiation—a category that also includes visible light, radio waves, and microwaves. Non-ionizing radiation does not carry enough energy to remove electrons from atoms or break chemical bonds in DNA. This is the fundamental reason red light is biologically distinct from UV radiation, X-rays, and gamma rays, which are ionizing and can cause cellular damage.

UV light from the sun sits at wavelengths below 400nm and has enough energy to damage DNA directly—this is how UV exposure causes sunburn, accelerates aging, and contributes to skin cancer. Red light at 660nm carries roughly half the photon energy of UV light. It stimulates cellular activity without damaging genetic material. The distinction is not subtle: it is the difference between a photon that can break a covalent bond and one that cannot.

Non-Thermal Effects at Therapeutic Doses

A common concern is whether red light panels generate enough heat to damage tissue. At therapeutic irradiance levels (typically 20–200 mW/cm²) and recommended distances (6–18 inches), the light reaching your skin does not generate significant thermal effects. You may feel mild warmth—this is photon absorption generating low-level heat—but it is well below the thermal injury threshold. Thermal damage from a red light therapy panel used at recommended distances would require irradiance levels orders of magnitude higher than any consumer device produces.

Decades of Research: The Safety Evidence Base

Photobiomodulation research dates to the 1960s. Over six decades of investigation across thousands of studies, in clinical trials involving tens of thousands of patients, no pattern of serious systemic adverse effects has emerged from therapeutic use. This accumulated evidence base is what allows researchers and regulatory bodies to characterize red light therapy as a low-risk intervention. The signal-to-noise ratio on safety is strong.

Regulatory Status

Multiple red light therapy devices have received FDA clearance through the 510(k) pathway for specific indications including pain relief, temporary muscle relaxation, and skin conditions. The FDA's decision to clear these devices reflects its review of safety data, not just efficacy. Several devices are also CE-marked for the European market and TGA-listed in Australia, reflecting international regulatory acceptance of the safety profile.

1. Known Side Effects: An Honest Assessment

The side effects associated with red light therapy are mild, transient, and uncommon. Here is an honest inventory of what the literature documents.

Temporary Eye Strain or Headache

High-intensity LEDs are bright. Looking directly at a panel—even for a few seconds—can cause temporary eye strain, similar to looking at any bright light source. Some users report mild headaches in the first few sessions, likely due to unaccustomed bright light exposure. This resolves with consistent use and is easily avoided by closing your eyes, wearing goggles, or looking away during sessions. It is not an indication of any harmful biological effect.

Skin Warmth and Temporary Redness

Some users experience mild skin warmth or temporary superficial redness following a session, particularly with higher-power panels at close distances. This is generally harmless and resolves within minutes to an hour. People with very fair skin, rosacea, or light-sensitive skin conditions may be more susceptible. If redness persists beyond a few hours, reduce session time or increase distance from the panel.

Fatigue in Early Sessions

A subset of new users report feeling tired after their first few sessions. This may reflect a genuine cellular response—red light stimulates mitochondrial activity and, theoretically, the body's initial adaptation to increased ATP production could feel like mild fatigue. This effect is typically transient and resolves after the first week of use. Starting with shorter sessions (5–10 minutes) can minimize this initial response.

Increased Appetite

Some users report a modest increase in appetite following red light therapy, particularly after full-body sessions. Research suggests this may reflect genuine metabolic stimulation—increased cellular energy production can drive hunger. This is not a harmful side effect per se, but it is worth being aware of if you are tracking caloric intake.

Rare Reports of Skin Sensitivity

Individuals with photosensitive skin conditions (such as lupus erythematosus, porphyria, or xeroderma pigmentosum) or those taking photosensitizing medications may experience heightened skin reactions. This is a genuine contraindication covered in detail in the medications and contraindications sections below.

What Side Effects Are NOT Common

Despite claims circulating online, the following are not documented side effects of properly applied red light therapy: permanent skin damage, DNA mutations, cancer, hormonal disruption, organ damage, or neurological effects. These fears are not supported by the scientific literature.

2. EMF Safety Deep Dive

EMF (electromagnetic field) concerns are among the most common questions about red light therapy panels. Here is a rigorous, evidence-based breakdown.

What Is EMF and Why Does It Matter?

All electrical devices emit electromagnetic fields. EMF exists on a spectrum from extremely low frequency (ELF-EMF from power lines) to radiofrequency (RF-EMF from Wi-Fi and cell phones) to ionizing radiation (X-rays). The health effects of non-ionizing EMF are an active area of research. Current WHO and scientific consensus is that the EMF produced by consumer electronics at typical exposure levels does not cause adverse health effects, though research is ongoing.

EMF from Red Light Therapy Panels

Red light therapy panels are LED-based electrical devices and do emit low-frequency EMF from their power supplies and wiring. However, EMF follows an inverse-square law: it drops rapidly with distance. At 12–18 inches from a typical panel—the recommended usage distance—EMF readings from quality panels are often lower than those from a smartphone held to your ear or a laptop resting on your lap.

Low-EMF Brands and Testing

The better brands in the industry publish independent third-party EMF testing data. Hooga's Pro series panels are designed with low-EMF components and publish irradiance and EMF data. PlatinumLED also makes low-EMF claims with supporting data. When evaluating any panel, look for independently verified EMF measurements at the distances you'll actually be using the device—not just at 0 inches from the surface.

Realistic EMF Risk Assessment

If you are highly EMF-sensitive or concerned about cumulative EMF exposure from all sources, choosing a low-EMF certified panel and using it at 12+ inches is a straightforward mitigation. For the general population, the EMF from a quality red light panel used at standard distances is not a significant health concern based on current evidence.

3. Flicker & Health Concerns

LED flicker is a less-discussed but legitimate consideration, particularly for specific populations.

What Is LED Flicker?

All LED lights cycle on and off based on the frequency of their power supply (50 or 60 Hz in most countries). Low-quality LED drivers can produce visible or invisible flicker—rapid fluctuations in light output. Visible flicker is obvious and annoying. Invisible flicker at frequencies below 100 Hz can cause eye strain, headaches, and is a documented concern for individuals with photosensitive epilepsy and migraines.

Flicker in Red Light Therapy Panels

High-quality red light therapy panels use constant-current drivers that minimize flicker. Budget panels with cheap driver electronics may produce significant flicker. When researching devices, look for panels that specify "flicker-free" or "DC-driven" components, or check independent reviews that test for flicker. Our panel rankings note flicker characteristics where data is available.

Who Should Prioritize Low-Flicker Devices

Individuals with photosensitive epilepsy, migraine disorders, or known sensitivity to flickering light should prioritize verified low-flicker panels. For the general population, flicker from a quality panel is unlikely to cause problems, especially with eyes closed or averted during sessions.

4. Eye Safety: Do You Need Goggles?

Eye safety is a common and legitimate concern. Here is the nuanced reality.

The Actual Risk to Eyes

The primary risk from red light therapy panels to the eyes is the same as from any bright light source: photochemical stress from extended direct viewing of high-intensity LEDs. Red and near-infrared light at 660–850nm does not carry the UV wavelengths responsible for cataract formation or retinal UV damage. However, very high-intensity near-infrared light (which is invisible to the human eye) can, in extreme cases, cause thermal stress to the retina if stared into at close range for extended periods.

To put this in perspective: consumer red light panels are a fraction of the power of medical-grade laser devices that require mandatory eye protection. The risk from a consumer panel is real but contextually low.

When Goggles Are Recommended

Eye protection is specifically recommended in these situations: when treating areas around the eyes or forehead; when using high-power full-body panels at close distances (6 inches or less); when the individual has existing eye conditions such as glaucoma, macular degeneration, or history of retinal surgery; and for any child using the device. The appropriate goggles are inexpensive and worth having on hand.

When Goggles Are Not Strictly Required

For full-body sessions where you are treating your torso, back, or legs—simply closing your eyes or looking away from the panel is adequate for the vast majority of users. Many users complete their entire sessions with eyes closed without issue. The precautionary step of looking away costs nothing and eliminates the theoretical risk.

Research on Photobiomodulation and Eye Health

Interestingly, research published in journals such as Photomedicine and Laser Surgery suggests that low-level red and near-infrared light may actually support eye health. Studies have investigated photobiomodulation for age-related macular degeneration, diabetic retinopathy, and dry eye syndrome with promising early results. This does not mean you should expose your eyes without caution, but it contextualizes the risk profile significantly.

5. FDA Clearance Explained

FDA clearance is frequently cited in red light therapy marketing. Here is what it actually means—and what it doesn't. (For a list of which LED masks are actually cleared, and why most panels are 510(k)-exempt, see our FDA-cleared red light therapy guide.)

The 510(k) Pathway

Most cleared red light therapy devices go through the FDA's 510(k) premarket notification pathway. This process requires the manufacturer to demonstrate that their device is "substantially equivalent" to a legally marketed predicate device. Clearance through 510(k) is not an approval based on randomized controlled trials proving efficacy. It is a determination of safety and equivalence to an existing benchmark device.

What FDA Clearance Means for Consumers

A cleared device has passed FDA review for its stated indication, which is a meaningful signal. The cleared indications for many red light devices include temporary relief of minor muscle and joint pain, relaxation of muscle spasms, temporary relief of minor arthritis pain, and improved local circulation. Clearance for these indications does not automatically extend to other uses (skin rejuvenation, hair growth, etc.).

Cleared vs. Non-Cleared: Does It Affect Quality?

Many excellent, rigorously tested devices are not FDA-cleared—not because they are unsafe or ineffective, but because the clearance process is expensive (FDA's review fee alone was $26,067 for a standard 510(k) in fiscal 2026, before testing costs) and time-consuming, and because many panels are listed as infrared heating lamps that are exempt from 510(k) review. Some direct-to-consumer brands with strong independent testing data and transparent irradiance specs opt not to pursue clearance for consumer panels. Absence of FDA clearance does not mean a device is inferior or unsafe; it means the manufacturer chose not to (or has not yet) pursued that process.

When evaluating any panel, prioritize: independently verified irradiance measurements, transparent EMF data, clear wavelength specifications, and a track record of user safety—regardless of clearance status. Our buying guide covers how to evaluate these specs in detail.

6. Contraindications: Who Should NOT Use RLT

Red light therapy is not appropriate for everyone. The following are genuine, evidence-supported contraindications or situations requiring physician consultation before use.

Active Cancer in the Treatment Area

This is the most significant contraindication. The cellular stimulation mechanisms of red light therapy—including enhanced proliferation signals—raise theoretical concerns about promoting tumor growth in active cancer cases. The evidence is mixed and not conclusive, but the precautionary principle applies. If you have an active malignancy, do not use red light therapy on or near the affected area without explicit clearance from your oncologist. Some integrative oncology practices do use photobiomodulation therapeutically under supervision—this is a decision for your medical team, not a consumer guide.

Seizure Disorders and Epilepsy

LED flicker, even at non-visible frequencies, can be a seizure trigger in individuals with photosensitive epilepsy. People with any seizure disorder should consult their neurologist before using red light therapy and should prioritize verified low-flicker panels if cleared to use them.

Thyroid Conditions

There is some evidence that red light in the 630–850nm range can affect thyroid tissue. Case reports and small studies suggest photobiomodulation may reduce the dose of thyroid hormone medication needed in some patients—which can be beneficial in a supervised clinical context but problematic if you are self-treating and not monitoring thyroid levels. People with thyroid conditions should avoid direct neck exposure and consult their endocrinologist.

Light-Sensitive Conditions

Certain medical conditions cause systemic or cutaneous photosensitivity: lupus erythematosus (particularly cutaneous and systemic lupus), porphyria, xeroderma pigmentosum, and solar urticaria. Individuals with these conditions may experience exacerbated symptoms from light therapy and should consult a dermatologist or rheumatologist before use.

Children

There is insufficient safety data for children using consumer red light therapy panels. Children's eyes are more sensitive to light, their skin is thinner, and their developing tissues may respond differently to photobiomodulation. Pediatric therapeutic use does occur in clinical settings under medical supervision, but unsupervised home use in children is not recommended.

Recent Steroid Injections

Some practitioners advise caution around recently injected areas, as the interaction between corticosteroid injections and photobiomodulation has not been adequately studied. A conservative guideline is to wait at least two weeks after a steroid injection before applying red light to the same area.

7. Drug Interactions & Medications

Photosensitizing medications are the most clinically significant category of drug interactions with red light therapy. These drugs increase the skin's sensitivity to light, potentially causing accelerated or exaggerated skin reactions.

Common Photosensitizing Medication Categories

The following drug classes are known photosensitizers. This list is not exhaustive—always review your medication's prescribing information and consult your physician:

• Antibiotics: Tetracyclines (doxycycline, minocycline), fluoroquinolones (ciprofloxacin, levofloxacin), sulfonamides
• Retinoids: Isotretinoin (Accutane), tretinoin, adapalene—these dramatically increase skin sensitivity to all light wavelengths
• NSAIDs: Ibuprofen, naproxen, and ketoprofen in topical forms are notable photosensitizers
• Antifungals: Certain systemic antifungals including voriconazole
• Diuretics: Thiazide diuretics (hydrochlorothiazide) are common photosensitizers often overlooked
• Antidepressants: Some tricyclic antidepressants and phenothiazines
• Chemotherapy agents: Multiple chemotherapy drugs increase photosensitivity; oncology team guidance is mandatory
• Certain supplements: St. John's Wort is the most notable supplement-level photosensitizer

What to Do If You Are on These Medications

If you are taking any photosensitizing medication, consult your prescribing physician before starting red light therapy. The interaction may not be absolute—some individuals on these medications use red light therapy without adverse effects—but the risk is real and individual variation is significant. Your doctor can assess whether the risk profile is acceptable for your specific situation, medication dose, and treatment goals.

Anti-Inflammatory Medications

There is a theoretical interaction between NSAIDs/corticosteroids and red light therapy: both modulate inflammatory pathways, and combining them may produce additive, subadditive, or unpredictable effects on the inflammatory cascade. This does not mean the combination is dangerous, but it is an area where clinical monitoring is prudent if you are using both for the same condition.

8. Pregnancy & Red Light Therapy

Pregnancy is an area where honest uncertainty is warranted rather than false reassurance.

The State of the Evidence

There are no well-designed clinical trials evaluating the safety of consumer red light therapy during human pregnancy. The absence of evidence is not evidence of safety—it is a genuine data gap. Some animal studies using photobiomodulation in pregnancy contexts have been conducted, generally without adverse findings, but animal data cannot be directly extrapolated to human pregnancy safety.

Theoretical Concerns

The main theoretical concerns around pregnancy and red light therapy center on direct abdominal exposure: photobiomodulation is known to affect cellular proliferation, mitochondrial activity, and circulation. During critical periods of fetal development, unpredictable stimulation of these pathways is a reason for precaution. There is no established evidence of harm, but there is also no safety data—a meaningful distinction.

Practical Recommendations

The conservative and defensible recommendation is to avoid direct abdominal and pelvic exposure during pregnancy. Use of red light on the face, extremities, or back may carry lower theoretical risk, but this is not a guarantee of safety—it is a risk gradient. Any use during pregnancy should be discussed with your OB-GYN. Many practitioners advise avoiding RLT during the first trimester entirely given the sensitivity of early fetal development.

9. Red Light Therapy Myths Debunked

Several persistent myths about red light therapy safety circulate online. Here is what the evidence actually shows.

Myth 1: "Red Light Causes Cancer" — FALSE

Red light at 630–850nm is non-ionizing radiation that cannot damage DNA. There is no mechanism by which therapeutic red light exposure could initiate carcinogenesis in healthy tissue. Multiple systematic reviews have found no evidence of carcinogenic effects. The confusion often arises from conflating red light with UV light—a category error that fundamentally misrepresents the physics. See the science guide for a full explanation of photon energy and wavelength biology.

Myth 2: "It's Just Marketing Hype" — FALSE

While exaggerated claims exist in the industry, photobiomodulation is supported by over 4,000 peer-reviewed studies published in journals including Nature, JAMA, and Lasers in Surgery and Medicine. The biological mechanisms are well-characterized: cytochrome c oxidase photon absorption, mitochondrial membrane potential changes, ATP upregulation, and secondary signaling cascades are documented effects. The benefits pillar reviews 25 evidence-supported applications with study citations.

Myth 3: "All Red Light Devices Are the Same" — FALSE

Device quality varies enormously. Irradiance, wavelength accuracy, EMF output, flicker characteristics, and build quality differ significantly between a $30 Amazon LED and a $500 professional panel. The therapeutic dose delivered depends entirely on actual irradiance at the usage distance—a spec that budget devices frequently misrepresent. Our panel rankings use independently verified irradiance data, not manufacturer claims.

Myth 4: "More Light = Faster Results" — FALSE

Red light therapy exhibits a biphasic dose response: below-optimal doses produce weak effects, optimal doses produce maximal effects, and above-optimal doses can inhibit or reverse the benefit. This is not theoretical—it is demonstrated consistently across cell culture, animal, and human studies. Overdosing is a real phenomenon. Doubling your session time does not double your results and may reduce them. The protocols guide provides evidence-based dose ranges by condition.

Myth 5: "Red Light Can Burn Your Skin" — MOSTLY FALSE

Consumer red light panels used at recommended distances do not produce sufficient irradiance to cause thermal skin injury. Skin burns from LED panels would require holding the panel directly against the skin for extended periods, which no protocol recommends. The warmth you feel during a session is photon absorption, not tissue heating. People with extremely sensitive skin may experience mild temporary redness, but this is not a burn.

Myth 6: "It Interferes With Natural Healing" — FALSE

This myth has it exactly backwards. Photobiomodulation is one of the most extensively studied accelerators of natural healing processes. Studies show it reduces inflammation, increases collagen synthesis, enhances fibroblast activity, and accelerates wound healing. It works by augmenting the body's own cellular repair mechanisms—not by suppressing or replacing them.

Myth 7: "Only FDA-Cleared Devices Work" — FALSE

FDA clearance status has no direct relationship to therapeutic efficacy. Clearance is a regulatory determination, not a performance benchmark. Many non-cleared panels deliver superior irradiance, verified wavelengths, and better build quality than cleared devices. Clearance is one data point; independent testing data is more informative for consumer purchasing decisions.

10. Realistic Risk Assessment

Context matters in risk evaluation. How does red light therapy actually compare to other common health interventions?

Adverse Event Rates in the Literature

Published systematic reviews on photobiomodulation consistently report adverse event rates below 1–2%, with the vast majority being mild and transient (skin redness, temporary eye strain, headache). Serious adverse events requiring medical intervention are extremely rare in the literature and generally involve off-label use, contraindicated populations, or devices operated far outside recommended parameters.

Comparison to Common Alternatives

To put the safety profile in perspective: long-term NSAID use carries documented risks of gastrointestinal bleeding (1–2% per year), cardiovascular events, and kidney damage. UV tanning causes DNA damage with each exposure and is a recognized carcinogen. Cortisone injections carry risks of tendon weakening, cartilage damage, and infection. Surgical interventions carry anesthesia risks, infection risks, and complications. Against this backdrop, red light therapy's side effect profile is genuinely mild.

Long-Term Safety

Long-term use data comes primarily from clinical laser therapy (which uses the same wavelengths at higher intensities). Decades of clinical laser therapy use in medical practice have not revealed patterns of delayed toxicity, cumulative organ damage, or long-term adverse effects in properly screened patients. Consumer panel use at lower irradiance levels does not present a higher long-term risk profile.

The Bottom Line on Risk

For healthy adults without the specific contraindications listed in this guide, red light therapy presents a low-risk profile. The theoretical risks frequently cited online (cancer, DNA damage, organ toxicity) are not supported by the evidence base. The real risks—medication interactions, contraindicated conditions, eye strain—are manageable with basic precautions and physician consultation where appropriate.

11. When to Consult a Doctor

In the following situations, consult your physician before beginning red light therapy:

• You have any active or past cancer diagnosis, regardless of treatment status
• You take any prescription medication (review for photosensitizing properties)
• You have a seizure disorder, epilepsy, or migraine disorder triggered by light
• You have a diagnosed thyroid condition
• You are pregnant or trying to conceive
• You have an autoimmune condition affecting the skin (lupus, dermatomyositis)
• You have had recent eye surgery or have a diagnosed retinal condition
• You have a pacemaker or implanted electronic device (direct panel-to-device proximity is inadvisable)

What to Tell Your Doctor

Many physicians are unfamiliar with consumer red light therapy. Bring data: the device's wavelength range, irradiance specifications, your intended protocol (session length, frequency, treatment area). Frame it in terms of photobiomodulation at the wavelengths you'll be using. This gives your physician the information needed to make an informed recommendation rather than a reflexive prohibition based on unfamiliarity.

12. Safe Usage Framework

For healthy adults cleared to use red light therapy, these guidelines minimize the already-low risk profile.

Start Low, Go Slow

Begin with shorter sessions at greater distances. A first-week protocol of 5–10 minutes at 18 inches, three times per week, allows you to assess your individual response before increasing dose. Watch for any skin reactions, headaches, or other unexpected responses. If all is well after one week, progress according to your condition-specific protocol from our dosing guide.

Protect Your Eyes

Close your eyes or wear goggles during sessions—particularly when treating the upper body or face. This simple step eliminates the primary eye-related risk at no cost.

Respect the Biphasic Dose Response

More is not better. Stick to the evidence-based dose ranges: 10–20 minutes per treatment area per session, 3–5 sessions per week, at 6–18 inches from the panel depending on its irradiance. If you are not seeing results after 4–6 weeks, the issue is more likely protocol inconsistency or device quality than insufficient dosing.

Signs to Stop and Reassess

Discontinue use and consult a healthcare provider if you experience: persistent skin redness (lasting more than 2 hours), new or worsening pain in the treated area, significant fatigue or systemic symptoms following sessions, or any unusual skin changes. These are uncommon but indicate the need for professional evaluation.

Choose a Quality Device

Device quality affects safety. A panel with transparent irradiance data, low-EMF components, and quality LED drivers reduces the already-low risks further. Our top-rated panels include the Hooga HGPro1500 and Hooga HG1500, both of which publish independent testing data. For smaller targeted use, the Hooga HGPro300 is a well-tested entry-level option.

Frequently Asked Questions

Conclusion: Red Light Therapy Is Generally Safe When Used Properly

After reviewing the full body of safety evidence, the conclusion is straightforward: red light therapy has an excellent safety profile for most healthy adults who follow basic precautions. The mechanisms of action are well-characterized, the adverse event rates in clinical literature are low, and the serious theoretical risks (cancer, DNA damage, organ toxicity) are not supported by decades of research involving tens of thousands of patients.

The real safety considerations are narrower and more specific than internet fear-mongering suggests: medication interactions with photosensitizers, contraindications for specific medical conditions, eye protection during face-area treatments, and appropriate caution during pregnancy. These are not reasons to avoid red light therapy—they are the guardrails that define safe use for the appropriate population.

If you are a healthy adult without the contraindications discussed in this guide, you can begin red light therapy with confidence. Start conservatively, protect your eyes, choose a quality device with transparent specifications, and follow an evidence-based protocol. If you have any of the conditions listed in the contraindications section, a short conversation with your physician is the appropriate next step.

Ready to choose a device? Our complete buying guide walks through every specification that matters for safety and effectiveness. For ranked panel options with verified specs, see our best panels guide. And once you have a device, our protocols guide provides evidence-based dosing for every common goal. Red light therapy is a tool that rewards careful, consistent use—and the science of its safety is one of its strongest features.